医学
阿尔法
艾博汀阿尔法
荟萃分析
肾脏疾病
内科学
安慰剂
危险系数
优势比
随机对照试验
重症监护医学
贫血
置信区间
替代医学
病理
作者
Edmund Y. M. Chung,Suetonia C. Palmer,Valeria Saglimbene,Jonathan C. Craig,Marcello Tonelli,Giovanni FM Strippoli
出处
期刊:The Cochrane library
[Elsevier]
日期:2023-02-13
卷期号:2023 (2)
被引量:15
标识
DOI:10.1002/14651858.cd010590.pub3
摘要
Erythropoiesis-stimulating agents (ESAs) are commonly used to treat anaemia in people with chronic kidney disease (CKD). However, their use has been associated with cardiovascular events. This is an update of a Cochrane review first published in 2014.
科研通智能强力驱动
Strongly Powered by AbleSci AI